## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-05T14:36:15.255Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Top 200 Drugs Study"
developer_entity: "Polemics Applications LLC"
bundle_id: "polemics.top200drugs"
app_store_id: "1132919243"
category: "Education"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2025-04-25"
report_date: "2026-05-05"
report_version: "3.0"
total_reviews: 2
overall_rating: 3
sentiment: "Upset"
sentiment_score: 10
confidence: "low"
confidence_score: 0.35
top_complaint_theme: "Outdated medical information in the current version prevents professional use for clinical reference"
review_sample_size: 1
total_review_count: 1
analyzed_review_count: 1
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 2
nemesis: "Drugs.com Medication Guide"
competitor_count: 6
tags: ["education", "paid", "upset sentiment", "mobile app", "app review", "app analysis", "healthcare", "students,", "pharmacy"]
canonical_url: "https://marlvel.ai/intel-report/education/top-200-drugs-study"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Top 200 Drugs Study App Audit

## TL;DR {#tldr}

- **Category**: Education · Paid
- **Signal**: Rating 3 · Sentiment Upset
- **Recent focus**: Outdated medical information in the current version prevents professional use for clinical reference (top complaint)

> **TL;DR:** Top 200 Drugs Study is a education app by Polemics Applications LLC, rated 3/5 by 2 users, with Upset user sentiment (10/100), available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Top 200 Drugs Study faces Upset user sentiment (3/5 from 2 reviews), with outdated medical information in the current version prevents professional use for clinical reference as the primary user concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 3/5 (2 reviews) |
| **User Mood** | Upset |
| **Category** | Education |
| **Developer** | Polemics Applications LLC |
| **Pricing** | Paid |
| **Platforms** | iOS |
| **Confidence** | Low (0.35/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Polemics Applications LLC
- **Category:** Education
- **Target Audience:** Healthcare students, pharmacy technicians, and medical professionals preparing for board exams or requiring quick pharmacology reference.
- **Platforms:** iOS
- **Version Audited:** 3.0
- **Audit Date:** 2026-05-05
- **Signal Count:** 1 reviews analyzed
- **Confidence:** Low (0.35/1.0)
- **App Store ID (iOS):** 1132919243
- **Bundle ID:** polemics.top200drugs
- **Data Window:** Analysis based on signals collected up to 2026-05-05

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Top 200 Drugs Study is a mobile flashcard and quiz application for healthcare students and professionals.
**Why users hire it:** Users hire the app to master pharmacology for board exams via active recall, but the current content decay prevents it from serving as a reliable clinical reference.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Flash Card Study:** Nine question types covering 1800+ cards with customizable deck sizes and favorite save functionality
  * *User Intent:* Users value self-expression and personalized experiences.
- **[Differentiator] Dictionary Mode:** Searchable drug database with Wikipedia integration for detailed pharmaceutical information
  * *User Intent:* Users want to quickly find relevant content or features.
- **[Standard] Quiz Mode:** Multiple-choice testing with randomized answers and progress tracking for active recall
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Guided Learning:** Custom study set creation for specific medication groups or exam preparation
  * *User Intent:* Users value self-expression and personalized experiences.
- **[Differentiator] Cheat Sheet Export:** Quick pharmacology topics exportable via text and email
  * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app maintains a niche position in the education category, but its 3-star rating and lack of recent content updates signal a decline in utility compared to professional-grade incumbents.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** One-time purchase at $1.99
- **Price:** iOS: $1.99
- **Analysis:** The app utilizes a low-cost, one-time purchase model, positioning it as an accessible utility for students and professionals.

<!-- section:sentiment -->
## 🔴 User Sentiment (Low Confidence: 1 of 1 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 3/5
- **Platform Split:** iOS 3.0/5 (2 ratings)
- **Overall Sentiment:** Upset

### Top Complaints (Impact Areas)
- **Outdated medical information in the current version prevents professional use for clinical reference**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Distraction-free interface optimizes for rapid study sessions
- Cheat Sheet export enables viral distribution among student cohorts

**Critical Frictions:**
- Content decay renders the database unreliable for clinical use
- 3.0-star rating reflects user frustration with outdated medication lists

**Growth Levers:**
- Integrate AI-driven deck generation to compete with Turbo AI
- Pivot to a subscription model to fund continuous clinical database updates

**Market Threats:**
- Drugs.com's high-velocity update cadence makes manual database maintenance unsustainable
- AI-automated study tools reduce the value of static, pre-built flashcard decks

<!-- /section:swot -->
<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Top 200 Drugs Study vs Drugs.com Medication Guide — Head to Head
- **[Drugs.com Medication Guide](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide)** by Drugs.com: This is the primary direct rival due to its specialized focus on medication reference, high-frequency updates, and established authority in the medical domain.
  - **Moat strength:** High — sustainable advantage over 12 months
  - **Key differences:**
    - Maintains a comprehensive, professionally curated drug database that serves as a primary source of truth for clinicians.
    - Offers deep integration with clinical decision support tools that go far beyond simple flashcard-based study aids.
    - Provides real-time medication safety alerts and interaction checkers that provide immediate utility to practicing healthcare professionals.
  - **Where Top 200 Drugs Study wins:**
    - ✅ Focuses exclusively on student-centric study modes like quiz-based flashcards to optimize for exam preparation and rote memorization.
    - ✅ Provides a lightweight, distraction-free interface specifically designed for rapid study sessions rather than clinical reference.
  - **Where Drugs.com Medication Guide wins:**
    - ❌ Leverages massive brand authority and institutional trust to capture both student and professional user segments simultaneously.
    - ❌ Delivers continuous, high-velocity content updates that ensure medical information remains accurate and compliant with current standards.
  - **Verdict:** The target app must pivot toward specialized student-focused features like spaced-repetition algorithms to differentiate from the clinical reference utility of Drugs.com.

### Contenders (Strong Challengers)
- **Picmonic Nursing & NCLEX Study** by Picmonic - The Visual Learning Community [Moat: Medium]: Directly competes for the same student audience by utilizing visual mnemonic learning strategies for medical pharmacology.
  - Utilizes proprietary visual mnemonic storytelling to improve long-term retention of complex pharmacological concepts.
  - Offers specialized content tracks tailored specifically for nursing students and NCLEX exam preparation requirements.
- **[Medscape](https://marlvel.ai/intel-report/medical/medscape)** by WebMD [Moat: High]: A massive incumbent in the medical space that provides a broader suite of tools including news and clinical reference.
  - Integrates daily medical news and professional education modules alongside standard drug reference databases.
  - Provides a comprehensive ecosystem that supports the entire career lifecycle of a healthcare professional.

### Peers (What They Do Better)
- **[Quizlet: More than Flashcards](https://marlvel.ai/intel-report/education/quizlet-more-than-flashcards)** by Quizlet Inc: A dominant general-purpose study platform that competes for the same student time-share via user-generated flashcard decks.
  - Leverages massive network effects through millions of user-created study sets across every academic discipline.
  - Provides advanced AI-powered study modes that adapt to user performance and specific learning gaps.
- **[AnkiMobile Flashcards](https://marlvel.ai/intel-report/education/ankimobile-flashcards)** by Anki Software, LLC: The gold standard for serious medical students using spaced-repetition systems for high-volume pharmacology memorization.
  - Features a highly sophisticated, open-source spaced-repetition algorithm that is the industry standard for medical board prep.
  - Supports complex media types and custom card templates that allow for deep customization of study materials.

### New Kids on the Block (What's Innovative)
- **[Turbo AI - Notetaker](https://marlvel.ai/intel-report/education/ai-turbolearn)** by TurboLearn AI: Represents the shift toward AI-automated study material generation, threatening static flashcard apps with dynamic content creation.

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New {#recent-changes}

- **Latest (v1.0, 9 years ago):** General functionality improvements; no new features included.
- **Last Major (v1.1, 4 years ago):** Introduced a new interface and added new study features.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Added favorites feature to flash cards.
- Added pharmacology short articles.
- Added email-exportable Cheat Sheet.

> **Cadence:** 5 total versions · 4 majors in last 6 months · 375 days since last update · 298 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Top 200 Drugs Study is a challenged education app that is a paid app.
With a 3/5 rating from 2 reviews, it faces significant user friction.

<!-- speakable-start -->
> **Bottom Line:** The app provides a focused study environment but suffers from critical content decay, so the PM must prioritize a database audit to prevent total churn among the professional user base.
<!-- speakable-end -->

**Best for:** Healthcare students, pharmacy technicians, and medical professionals preparing for board exams or requiring quick pharmacology reference.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] [HIGH IMPACT] Audit and refresh the drug database because current content is outdated → restore professional trust — *User complaints highlight the exclusion of modern medications and inclusion of discontinued drugs.* _(trade-off: deprioritize Pause the development of new quiz modes; content accuracy is the primary churn driver.)_
- [ ] [INVEST] [MEDIUM IMPACT] Implement AI-automated study set generation because competitors like Turbo AI are reducing manual effort → maintain competitive parity — *The current manual deck creation is a friction point compared to emerging AI-native study tools.* _(trade-off: deprioritize Deprioritize the UI color palette maintenance; functional automation provides higher user value.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Real-time clinical decision support (available in Drugs.com but absent here)
- AI-automated study set generation (available in Turbo AI but absent here)
- Visual mnemonic learning tracks (available in Picmonic but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The pharmacology study market is shifting toward automated, high-velocity content delivery, leaving static apps like this one exposed. Without a pivot to automated updates or a subscription-funded content team, the app will continue to lose relevance to AI-native competitors.

- 🔴 Critical content decay in the latest version prevents professional use, which accelerates churn among the core student audience.
- 🔴 Manual database maintenance cannot keep pace with clinical standards, creating a widening trust gap against professional incumbents.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 3/5 |
| Total Reviews | 2 |
| Sentiment | Upset (10/100) |
| Confidence | Low |
| Pricing Model | Paid |
| Platforms | iOS |
| Key Features | 5 analyzed |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Top 200 Drugs Study** (this app) | 3/5 | Upset | Polemics Applications LLC |
| [Turbo AI - Notetaker](https://marlvel.ai/intel-report/education/ai-turbolearn) | 4.8/5 | N/A | TurboLearn AI |
| [Quizlet: More than Flashcards](https://marlvel.ai/intel-report/education/quizlet-more-than-flashcards) | 4.8/5 | Mixed | Quizlet Inc |
| [Drugs.com Medication Guide](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide) | 4.8/5 | Excited | Drugs.com |
| [Medscape](https://marlvel.ai/intel-report/medical/medscape) | 3.7/5 | N/A | WebMD |
| [AnkiMobile Flashcards](https://marlvel.ai/intel-report/education/ankimobile-flashcards) | 4.1/5 | N/A | Anki Software, LLC |

## Company Profile
- **Developer:** Polemics Applications LLC

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/top-200-drugs-study/id1132919243?uo=4)
- **Sources:** App store metadata, User reviews.

## Related Intel Reports
- [*Turbo AI - Notetaker*](https://marlvel.ai/intel-report/education/ai-turbolearn) (TurboLearn AI) — 4.8/5 Rating | N/A Sentiment
- [*Quizlet: More than Flashcards*](https://marlvel.ai/intel-report/education/quizlet-more-than-flashcards) (Quizlet Inc) — 4.8/5 Rating | Mixed Sentiment
- [*Drugs.com Medication Guide*](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide) (Drugs.com) — 4.8/5 Rating | Positive Sentiment
- [*Medscape*](https://marlvel.ai/intel-report/medical/medscape) (WebMD) — 3.7/5 Rating | N/A Sentiment
- [*AnkiMobile Flashcards*](https://marlvel.ai/intel-report/education/ankimobile-flashcards) (Anki Software, LLC) — 4.1/5 Rating | N/A Sentiment
- [*Flash Cards Flashcards Maker*](https://marlvel.ai/intel-report/education/flash-cards-flashcards-maker) (Infinite Wave Media, LLC) — 4.0/5 Rating | Mixed Sentiment
- [*Elevate - Brain Training Games*](https://marlvel.ai/intel-report/education/elevate-brain-training-games) (The Mind Company) — 4.7/5 Rating | Mixed Sentiment
- [*AlgoApp - Flashcards*](https://marlvel.ai/intel-report/education/algoapp-flashcards) (AlgoApp Inc) — 4.6/5 Rating | Mixed Sentiment
- [*Flashcards maker - AI generate*](https://marlvel.ai/intel-report/education/flashcards-maker-ai-generate) (Teleprompter LLC) — 4.1/5 Rating | Mixed Sentiment
- [*Flashcards Deluxe*](https://marlvel.ai/intel-report/education/flashcards-deluxe) (OrangeOrApple.com) — 4.5/5 Rating | Excellent Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.35/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 1
- **Data Sources:** user reviews, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/education/top-200-drugs-study)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.